Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ASP Isotopes (ASPI) EBITDA (2022 - 2025)

ASP Isotopes has reported EBITDA over the past 4 years, most recently at -$77.3 million for Q4 2025.

  • On a quarterly basis, EBITDA fell 545.07% to -$77.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$170.8 million, a 406.65% decrease, with the full-year FY2025 number at -$170.8 million, down 407.32% from a year prior.
  • EBITDA reached -$77.3 million in Q4 2025 per ASPI's latest filing, down from -$12.1 million in the prior quarter.
  • The five-year high for EBITDA was -$472642.0 in Q2 2022, with the low at -$77.3 million in Q4 2025.
  • The 4-year median for EBITDA is -$5.4 million (2023), against an average of -$14.2 million.
  • Peak YoY movement for EBITDA: plummeted 906.9% in 2023, then rose 2.82% in 2025.
  • Tracing ASPI's EBITDA over 4 years: stood at -$1.3 million in 2022, then crashed by 185.22% to -$3.8 million in 2023, then plummeted by 212.63% to -$12.0 million in 2024, then tumbled by 545.07% to -$77.3 million in 2025.
  • According to Business Quant data, EBITDA over the past three periods came in at -$77.3 million, -$12.1 million, and -$74.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.